Veritas Asset Management LLP Abbott Laboratories Transaction History

Veritas Asset Management LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $40,828 - $49,348	-400 Reduced 10.26%	3,500 $380,000
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $205,236 - $250,272	-1,800 Reduced 31.58%	3,900 $462,000
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $482 Million - $534 Million	-4,133,928 Reduced 99.86%	5,700 $673,000
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $75 Million - $88.3 Million	-709,130 Reduced 14.62%	4,139,628 $480 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $20.9 Million - $24.6 Million	-191,870 Reduced 3.81%	4,848,758 $581 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $1.16 Million - $1.26 Million	-11,000 Reduced 0.22%	5,040,628 $552 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $643,679 - $781,700	7,024 Added 0.14%	5,051,628 $550 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $339,741 - $434,826	-4,437 Reduced 0.09%	5,044,604 $461 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $317 Million - $464 Million	5,049,041 New	5,049,041 $398 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Veritas Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Veritas Asset Management LLP with notifications on news.